Your prediction
Adamis Pharmaceuticals Corp. Stock
Our community identified positive and negative aspects for Adamis Pharmaceuticals Corp. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Adamis Pharmaceuticals Corp. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Adamis Pharmaceuticals Corp. in the next few years
Pros
?
B****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Adamis Pharmaceuticals Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Adamis Pharmaceuticals Corp. | - | - | - | - | - | - | - |
| Rockwell Medical Inc. | 0.130% | 0.393% | -8.209% | -48.278% | 13.230% | -44.088% | -93.726% |
| Pacira Pharmaceuticals | 0.000% | 0.510% | 20.122% | -2.475% | -8.796% | -47.326% | -67.167% |
| Twist Bioscience Corp | -8.860% | -10.846% | -6.780% | 3.659% | 34.291% | 152.328% | -68.571% |
Comments
Adamis Pharmaceuticals Co. (NASDAQ: ADMP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ADMP provided by MarketBeat
